UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000005644
Receipt No. R000006668
Scientific Title Evaluation of cerebral blood flow before and after acupuncture stimulation using arterial spin-labeled MRI for migraine -uncontrolled, open label study-
Date of disclosure of the study information 2011/05/26
Last modified on 2020/11/09 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of cerebral blood flow before and after acupuncture stimulation using arterial spin-labeled MRI for migraine
-uncontrolled, open label study-
Acronym Japan Evaluation of cerebral blood flow before and after acupuncture stimulation using arterial spin-labeled MRI for migraine
JASCA study
Scientific Title Evaluation of cerebral blood flow before and after acupuncture stimulation using arterial spin-labeled MRI for migraine
-uncontrolled, open label study-
Scientific Title:Acronym Japan Evaluation of cerebral blood flow before and after acupuncture stimulation using arterial spin-labeled MRI for migraine
JASCA study
Region
Japan

Condition
Condition migaraine
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 In the update report of Cochrane review analyzing it has not yet been verified whether acupuncture is more useful than fake acupuncture (placebo), but in comparison with the efficacy-established preventive drug therapy, it was concluded that acupuncture is equivalent to or slightly more effective than the preventive drug therapy and induces less adverse events. We investigated the onset mechanism of tension-type headache and the action mechanism of acupuncture using plethysmography, EMG, thermography and open loop video pupillography. As a result, it was found that the hypertension of the posterior cervical, suprascapular and interscapular muscles play more important roles than the hypertension of the head muscles in the onset mechanism of headache, and acupuncture contributes to alleviation of headache by relaxing the hypertension of these muscles and normalizing the circulatory dynamics. It was further clarified that such analgesic mechanism has influences not only on the local reaction (axonal reflex) but also on the high-level central nervous system (Edinger-Westphal Nucleus / periaqueductal gray matter) and the autonomic nerve system is playing important roles.
Then, in this study, for the purpose of clarifying the mechanism of acupuncture against migraine, we will investigate the influences of acupuncture on the cerebral blood flow at the pain-sensitive sites of thalamus, hypothalamus, periaqueductal gray matter, ceruleus nucleus, nucleus raphe magnus, etc., which are considered to be the migraine-inducing organs, by determining the cerebral blood flow changes using ASL as an index
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes cerebral blood flow
Key secondary outcomes Headache diary

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 acupuncture
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria Migraine headache of the diplomatic relations verge headache classification second edition
Key exclusion criteria The subjects have history of cerebrovascular disorder
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Satoru
Middle name
Last name Yamaguchi
Organization Saitama Medical University
Division name The Center for Oriental and Integrated Medicine,Saitama Medical University, Saitama, Japan.
Zip code 350-0495
Address 38,Morohongo,Moroyamamachi,Iruma-gun,Saitama
TEL +81-(0)49-276-1274
Email sayama@saitama-med.ac.jp

Public contact
Name of contact person
1st name Satoru
Middle name
Last name Yamaguchi
Organization Saitama Medical University
Division name The Center for Oriental and Integrated Medicine,Saitama Medical University, Saitama, Japan.
Zip code 350-0495
Address 38,Morohongo,Moroyamamachi,Iruma-gun,Saitama
TEL +81-(0)49-276-1274
Homepage URL http://www.saitama-med.ac.jp/hospital/division_info/26.html
Email sayama@saitama-med.ac.jp

Sponsor
Institute Saitama Medical University
Institute
Department

Funding Source
Organization Saitama Medical University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization IRBl ,Saitama Medical University, Saitama, Japan.
Address 38,Morohongo,Moroyamamachi,Iruma-gun,Saitama
Tel 049-276-1354
Email hirb@saitama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 05 Month 26 Day

Related information
URL releasing protocol https://touyouigakuka.wixsite.com/touyou-2/blank-7
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 20
Results
The target cases are 11 patients with migraine (4 males and 7 females) and 11 healthy adults (6 males and 4 females).
Results date posted
2019 Year 06 Month 10 Day
Results Delayed
Delay expected
Results Delay Reason Because the analysis is delayed
Date of the first journal publication of results
Baseline Characteristics
migraine
Participant flow
Open call for participants
Diagnosis by a specialist
Inform outlet
Cerebral blood flow evaluation
Adverse events
none
Outcome measures
Cerebral blood flow 
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2010 Year 09 Month 01 Day
Date of IRB
2011 Year 07 Month 23 Day
Anticipated trial start date
2011 Year 07 Month 22 Day
Last follow-up date
2013 Year 03 Month 31 Day
Date of closure to data entry
2014 Year 03 Month 31 Day
Date trial data considered complete
2014 Year 03 Month 31 Day
Date analysis concluded
2014 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date
2011 Year 05 Month 25 Day
Last modified on
2020 Year 11 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006668